Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) are among the team supporting the newly established Australian Venom Innovation and Discovery (AVID) Initiative.
A new broad-spectrum coronavirus antiviral, ASAP-0017445, has been nominated as a pre-clinical drug candidate by the Drugs for Neglected Diseases initiative (DNDi).
Cuireadh roinnt torthaí i bhfolach toisc go bhféadfadh siad a bheith dorochtana duit
Taispeáin torthaí dorochtana
Aiseolas